Sort
48,018 grants matching “immunotherapy”
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$416,647E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2020 · NS
Core B: Clinical Core
$416,647Arthur Y Kim · Massachusetts General Hospital · U19 · FY2022 · AI
NONMYELOABLATIVE GRAFTS IN LITTERMATES
$416,641Fred Hutchinson Cancer Research Center · P01 · FY2003 · HL
Experimental Photoimmunotherapy of Ovarian Cancer
$416,540Massachusetts General Hospital · R01 · FY2004 · AR
HIFU-enhanced tumor vaccines
$416,537Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2011 · EB
BET degraders for improving colorectal cancer therapy
$416,526Lin Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Functional Activation of Low Affinity TILs
$416,524Jill E Slansky · University Of Colorado Denver · R01 · FY2021 · CA
Discovery & Validation of Biomarkers of Kidney Pathology
$416,495Brad H Rovin · Ohio State University · U01 · FY2015 · DK
Synthetic epigenetic circuits: tunable cell fate switches controlled by dynamic and combinatorial inputs
$416,467Wendell A Lim · University Of California, San Francisco · R01 · FY2025 · CA
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
$416,450Jonathan P Schneck · Johns Hopkins University · R33 · FY2019 · CA
Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer
$416,435Philip W Kantoff · Sloan-Kettering Inst Can Research · U01 · FY2018 · CA
COMPUTATIONAL TOOLS FOR THE ANALYSIS OF HIGH-THROUGHPUT IMMUNOGLOBULIN SEQUENCING EXPERIMENTS
$416,371Steven H. Kleinstein · Yale University · R01 · FY2021 · AI
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
$416,339Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2019 · GM
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
$416,323Fotios Asimakopoulos · University Of California, San Diego · R01 · FY2024 · CA
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
$416,290Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2025 · CA
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$416,279Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2024 · AI
Synaptic Control of Cytotoxic T cell Function
$416,276Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2017 · AI
Synaptic Control of Cytotoxic T cell Function
$416,276Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2016 · AI
Regulation of memory CD8 T cell development
$416,250Susan M Kaech · Yale University · R37 · FY2016 · AI
Engineering cellular immunotherapy to modulate immune responses in hemophilia
$416,250Valder R Arruda · Children'S Hosp Of Philadelphia · R01 · FY2018 · HL
Fc receptor/Ig interactions and trafficking
$416,250Pamela J Bjorkman · California Institute Of Technology · R01 · FY2016 · AI
Regulation of memory CD8 T cell development
$416,250Susan M Kaech · Yale University · R37 · FY2015 · AI
Engineering cellular immunotherapy to modulate immune responses in hemophilia
$416,250Ben J Samelson-Jones · Children'S Hosp Of Philadelphia · R01 · FY2019 · HL
Regulation of memory CD8 T cell development
$416,250Susan M Kaech · Yale University · R37 · FY2017 · AI
Regulation of memory CD8 T cell development
$416,250Susan M Kaech · Yale University · R37 · FY2014 · AI